Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bradbury Daniel
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   232,105    

Indirect Shares

   3,161,475      
Direct Value   $2,384,065    

Indirect Value

   $4,253,337      
Total Shares   3,393,580      
Total Value   $6,637,402      


Paratek Pharmaceuticals Inc $79,642 Illumina Inc $1,548,490 Geron Corporation $495,433 Castle Biosciences Inc $0 Nuvation Bio Ord Shs Class A $260,500 Paratek Pharmaceuticals Inc $79,642 Illumina Inc $1,548,490 Geron Corporation $495,433 Castle Biosciences Inc $0 Nuvation Bio Ord Shs Class A $260,500
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Amylin Pharmaceuticals Inc AMLN President & Chief Exec... 2012-08-08 0 2012-08-08 0    Premium*  
            Paratek Pharmaceuticals Inc PRTK Director 2006-05-09 35,714 0    Premium*  
            Illumina Inc ILMN Director 2017-05-25 15,324 2008-05-16 0    Premium*  
            Corcept Therapeutics Inc CORT Director 2012-11-21 0 2019-02-07 130,575    Premium*  
            Geron Corporation GERN Director 2014-05-09 142,776 2019-03-29 51,323    Premium*  
            Equillium Inc EQ Chief Executive Office... 2018-10-16 0 2018-10-16 2,969,596    Premium*  
            Castle Biosciences Inc CSTL Director 2024-05-25 13,291 2024-05-06 9,981    Premium*  
            Nuvation Bio Ord Shs Class A NUVB Director 2021-02-10 25,000 2021-02-10 0    Premium*  
* Premium Members only  

Records found :    424         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 17
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2006-10-06 4 AS $42.50 $127,500 I/I (3,000) 7,996 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2006-11-07 4 AS $44.51 $133,537 I/I (3,000) 4,996 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2006-12-07 4 AS $39.35 $98,369 I/I (2,500) 2,496 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2007-01-09 4 AS $38.51 $96,276 I/I (2,500) 11,394 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2007-01-31 4 A $36.07 $15,005 D/D 416 12,618 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2007-02-07 4 AS $40.52 $141,820 I/I (3,500) 7,894 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2007-02-28 4 A $33.07 $11,675 D/D 353 12,971 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2007-03-07 4 AS $37.00 $92,500 I/I (2,500) 5,394 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2007-03-22 4 OE $2.91 $488,911 D/D 39,269 52,240 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2007-03-23 4 GD $0.00 $0 I/I 1,297 4,097 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Operating   •       –      –    2007-03-23 4 GA $0.00 $0 I/I 1,297 5,770 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2007-04-09 4 AS $38.66 $96,657 I/I (2,500) 1,597 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2007-05-07 4 AS $41.90 $121,259 I/I (2,894) 37,972 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2007-06-29 5 GD $0.00 $0 I/I 1,450 36,522 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2007-08-30 5 GD $0.00 $0 I/I 32 36,490 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2007-10-05 5 GD $0.00 $0 I/I 150 36,340 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2007-10-09 5 GD $0.00 $0 I/I 21 36,319 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2007-10-31 5 GD $0.00 $0 I/I 215 36,104 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2007-11-16 4 OE $14.28 $134,884 I/I 9,445 47,417 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2007-12-10 5 GD $0.00 $0 I/I 300 45,249 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2007-12-31 5 GD $0.00 $0 I/I 137 45,112 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Exec Officer   •       –      –    2008-02-01 4 A $37.00 $6,734 D/D 182 13,330 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2008-03-04 4 GD $0.00 $0 I/I 40 46,369 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2008-03-19 4 GA $0.00 $0 I/I 1,790 6,263 0 -
AMLN Amylin Pharmaceuticals In... President & Chief Executive Of   •       •      –    2008-03-19 4 GD $0.00 $0 I/I 1,790 44,579 0 -
  424  Records found
  1   2   3  4   5   6   7   8   9   10   11   12   13   14   15   16   17      
  Page 3 of 17  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us